Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Rypdal, Maria"'
Autor:
Ohnstad, Hege Oma, Blix, Egil Støre, Akslen, Lars Andreas, Gilje, Bjørnar, Raj, Sunil Xavier, Skjerven, Helle, Borgen, Elin, Janssen, Emiel, Mortensen, Elin Synnøve, Brekke, Marianne B., Falk, Ragnhild Sørum, Schlichting, Ellen, Boge, Beate, Songe-Møller, Silje, Olsson, Pernilla Marie A., Heie, Anette, Mannsåker, Bård, Vestlid, Magdalena Aas, Kursetgjerde, Torgunn, Gravdehaug, Berit, Suhrke, Pål, Sánchez, E., Bublevic, J., Røe, Oluf Dimitri, Geitvik, Gry, Halset, Eline Holli, Rypdal, Maria Christine, Langerød, Anita, Lømo, Jon, Garred, Øystein, Porojnicu, Alina Carmen, Engebraaten, O., Geisler, Jürgen, Lyngra, Marianne, Hansen, M. H., Søiland, Håvard, Nakken, T., Asphaug, Lars, Kristensen, Vessela N., Sørlie, Therese, Sørlie, T., Nygård, Jan Franz, Kiserud, Cecilie E., Reinertsen, Kristin Valborg, Russnes, Hege Elisabeth Giercksky, Naume, Bjørn
Externí odkaz:
https://hdl.handle.net/11250/3160546
Autor:
Borgen, Elin, Rypdal, Maria Christine, Sosa, Maria Soledad, Renolen, Anne, Schlichting, Ellen, Lønning, Per Eystein, Synnestvedt, Marit, Aguirre-Ghiso, Julio, Naume, Bjørn
Publikováno v:
Borgen, Elin Rypdal, Maria Christine Sosa, Maria Soledad Renolen, Anne Schlichting, Ellen Lønning, Per Eystein Synnestvedt, Marit Aguirre-Ghiso, Julio Naume, Bjørn . NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. Breast Cancer Research. 2018, 20(1), 1-13
Breast Cancer Research
Breast Cancer Research
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, Lønning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, Naume, Bjørn
Figure S1. AE1AE3/NR2F1 DIF staining on normal MNCs spiked with breast cancer cell line cells. The first row shows normal MNCs (AE1AE2-negative) and one breast cancer cell line cell (MCF7; AE1AE3-positive). The MNCs contain 0–3 small/weak NR2F1 sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a13f65bdf12af42fe5db78dc1e52f66
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, Lønning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, Naume, Bjørn
Figure S2. Illustration of the classification system for NR2F1 expression of DTC prospectively chosen for the present study. NR2F1low DTC (A–C). (A) Cluster of three DTCs identified by AE1AE3 in red fluorescence and a morphology compatible with tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7264f1b5f5348a143138702071040aac
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S6. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile at last DIF DTC-positive BMA, restricted to those with Ki67 DTC analysis available (only patients being nonmetastatic at last DIF DTC-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d16d3e3039af3f749f42cd3d0f53772
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Table S2. Overview of patient material and DTC results. (DOCX 34 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05cc1d589c6216da9f37387b72bed070
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Table S4. Overview of received treatment between the two BM aspiration time points for the patients presented in Fig. 3. (DOCX 33 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e57a7345a042442536e27122539d8a2
Autor:
Borgen, Elin, Rypdal, Maria, Sosa, Maria, Renolen, Anne, Schlichting, Ellen, LøNning, Per, Synnestvedt, Marit, Aguirre-Ghiso, Julio, BjøRn Naume
Figure S6. (A) Survival analyses (time to systemic relapse/breast cancer death) in relation to NR2F1 profile at last DIF DTC-positive BMA, restricted to those with Ki67 DTC analysis available (only patients being nonmetastatic at last DIF DTC-positiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e5ad1fbeafb40a61ce314ae51d42454